ITULATEK — 1865432
Application number
1865432
Registration number
TMA1068693
Type(s)
Word
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2017-10-31
Registered
2020-01-09
Registration Expiry Date
2030-01-09
Registered Owner
ALK-ABELLO A/S
Bøge Allé 6-8
DK-2970 Hørsholm
DENMARK
Agent
DEETH WILLIAMS WALL LLP
150 YORK STREET, SUITE 400
TORONTO
ONTARIO M5H3S5
Documents
Index headings
- ITULATEK
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical and veterinary preparations, namely pharmaceutical and veterinary preparations for immunotherapeutic purposes in relation to allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis and respiratory allergic diseases, and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; diagnostic preparations for medical purposes, namely, for the treatment, monitoring and diagnosing of allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, diagnostic reagents and diagnostic testing materials for medical use in diagnosing, preventing and treating allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases.
Services (Nice class & Statement)
- 42
- (1) Medical and pharmacological research services in relation to allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; clinical trials.
- 44
- (2) Medical consulting services, namely counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; providing patient support relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums and electronically or digitally through the Internet; providing information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet.
Claims
- Proposed Use in CANADA
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2017-10-31 | ||
| Created | 2017-10-31 | ||
| Formalized | 2017-11-01 | ||
| Search Recorded | 2018-12-05 | ||
| Examiner's First Report | 2018-12-05 | 2019-06-05 | |
| Correspondence Created | 2019-06-04 | 2019-12-04 | |
| Approved | 2019-09-12 | ||
| Approval Notice Sent | 2019-09-12 | ||
| Advertised | 2019-10-02 | Vol.66 Issue 3388 | |
| Registration Pending | 2019-12-25 | ||
| Registration Fee Notice Sent | 2019-12-25 | 2020-06-25 | |
| Registered | 2020-01-09 | 2030-01-09 |